Qrativ’s Darwin.ai platform combines nference’s knowledge synthesis platform with the Mayo Clinic’s medical expertise and clinical data. The nference platform nferX uses neural networks to extract knowledge in real time from commercial, scientific, and regulatory literature. Qrativ partners can leverage the drug-purposing platform to search for all potential uses of a drug candidate, including identifying potential rare disease indications and finding subsets of patients who are most likely to respond to a given candidate.

Home page of this offering   provided by Qrativ